bionlp-st-ge-2016-spacy-parsed Home  

PMC:1064895 / 2420-2921 JSONTXT 26 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T3852 0-10 JJ denotes Rheumatoid
T3853 11-20 NNS denotes arthritis
T3854 21-22 -LRB- denotes (
T3855 22-24 NNP denotes RA
T3856 24-25 -RRB- denotes )
T3857 26-28 VBZ denotes is
T3858 29-42 VBN denotes characterized
T3859 43-45 IN denotes by
T3860 46-59 NNS denotes infiltrations
T3861 60-62 IN denotes of
T3862 63-74 NNS denotes macrophages
T3863 75-78 CC denotes and
T3864 79-80 NNP denotes T
T3865 81-86 NNS denotes cells
T3866 87-91 IN denotes into
T3867 92-95 DT denotes the
T3868 96-101 JJ denotes joint
T3869 101-102 , denotes ,
T3870 103-106 CC denotes and
T3871 107-115 JJ denotes synovial
T3872 116-127 NN denotes hyperplasia
T3873 127-128 . denotes .
T3874 129-144 JJ denotes Proinflammatory
T3875 145-154 NNS denotes cytokines
T3876 155-163 VBN denotes released
T3877 164-168 IN denotes from
T3878 169-174 DT denotes these
T3879 175-180 NNS denotes cells
T3880 181-184 VBP denotes are
T3881 185-190 VBN denotes known
T3882 191-193 TO denotes to
T3883 194-196 VB denotes be
T3884 197-206 JJ denotes important
T3885 207-209 IN denotes in
T3886 210-213 DT denotes the
T3887 214-225 NN denotes destruction
T3888 226-228 IN denotes of
T3889 229-235 NNS denotes joints
T3890 236-238 IN denotes in
T3891 239-241 NNP denotes RA
T3892 242-243 NNP denotes [
T3893 243-244 CD denotes 1
T3894 244-245 NNP denotes ]
T3895 245-246 . denotes .
T3896 247-250 DT denotes The
T3897 251-260 JJ denotes favorable
T3898 261-269 JJ denotes clinical
T3899 270-278 NNS denotes benefits
T3900 279-287 VBN denotes obtained
T3901 288-292 IN denotes with
T3902 293-303 NNS denotes inhibitors
T3903 304-306 IN denotes of
T3904 307-312 NN denotes tumor
T3905 313-321 NN denotes necrosis
T3906 322-328 NN denotes factor
T3907 329-330 -LRB- denotes (
T3908 330-333 NNP denotes TNF
T3909 333-334 -RRB- denotes )
T3910 334-335 : denotes -
T3911 335-336 VBN denotes α
T3912 336-337 -RRB- denotes )
T3913 338-341 CC denotes and
T3914 342-353 NN denotes interleukin
T3915 354-355 -LRB- denotes (
T3916 355-357 NNP denotes IL
T3917 357-358 -RRB- denotes )
T3918 358-360 CD denotes -1
T3919 361-368 VBP denotes suggest
T3920 369-373 IN denotes that
T3921 374-377 DT denotes the
T3922 378-386 NN denotes blockade
T3923 387-389 IN denotes of
T3924 390-393 JJ denotes key
T3925 394-406 JJ denotes inflammatory
T3926 407-416 NNS denotes cytokines
T3927 417-420 VBZ denotes has
T3928 421-425 VBN denotes been
T3929 426-429 DT denotes the
T3930 430-439 JJ denotes important
T3931 440-445 NN denotes issue
T3932 446-448 IN denotes in
T3933 449-452 DT denotes the
T3934 453-464 NN denotes development
T3935 465-467 IN denotes of
T3936 468-471 JJ denotes new
T3937 472-483 JJ denotes therapeutic
T3938 484-496 NNS denotes applications
T3939 497-498 JJ denotes [
T3940 498-499 CD denotes 2
T3941 499-500 NN denotes ]
T3942 500-501 . denotes .
R1821 T3852 T3853 amod Rheumatoid,arthritis
R1822 T3853 T3858 nsubjpass arthritis,characterized
R1823 T3854 T3853 punct (,arthritis
R1824 T3855 T3853 appos RA,arthritis
R1828 T3856 T3853 punct ),arthritis
R1829 T3857 T3858 auxpass is,characterized
R1832 T3858 T3858 ROOT characterized,characterized
R1833 T3859 T3858 agent by,characterized
R1836 T3860 T3859 pobj infiltrations,by
R1838 T3861 T3860 prep of,infiltrations
R1841 T3862 T3861 pobj macrophages,of
R1843 T3863 T3862 cc and,macrophages
R1845 T3864 T3865 compound T,cells
R1846 T3865 T3862 conj cells,macrophages
R1847 T3866 T3858 prep into,characterized
R1848 T3867 T3868 det the,joint
R1849 T3868 T3872 amod joint,hyperplasia
R1850 T3869 T3868 punct ",",joint
R1852 T3870 T3868 cc and,joint
R1855 T3871 T3868 conj synovial,joint
R1858 T3872 T3866 pobj hyperplasia,into
R1861 T3873 T3858 punct .,characterized
R1865 T3874 T3875 amod Proinflammatory,cytokines
R1869 T3875 T3881 nsubjpass cytokines,known
R1873 T3876 T3875 acl released,cytokines
R1878 T3877 T3876 prep from,released
R1880 T3878 T3879 det these,cells
R1883 T3879 T3877 pobj cells,from
R1887 T3880 T3881 auxpass are,known
R1891 T3881 T3881 ROOT known,known
R1894 T3882 T3883 aux to,be
R1898 T3883 T3881 xcomp be,known
R1901 T3884 T3883 acomp important,be
R1905 T3885 T3883 prep in,be
R1909 T3886 T3887 det the,destruction
R1913 T3887 T3885 pobj destruction,in
R1918 T3888 T3887 prep of,destruction
R1922 T3889 T3888 pobj joints,of
R1923 T3890 T3887 prep in,destruction
R1925 T3891 T3892 compound RA,[
R1929 T3892 T3890 pobj [,in
R1934 T3893 T3894 nummod 1,]
R1939 T3894 T3892 appos ],[
R1942 T3895 T3881 punct .,known
R1947 T3896 T3899 det The,benefits
R1951 T3897 T3899 amod favorable,benefits
R1955 T3898 T3899 amod clinical,benefits
R1958 T3899 T3911 nsubj benefits,α
R1962 T3900 T3899 acl obtained,benefits
R1966 T3901 T3900 prep with,obtained
R1969 T3902 T3901 pobj inhibitors,with
R1973 T3903 T3902 prep of,inhibitors
R1977 T3904 T3905 compound tumor,necrosis
R1983 T3905 T3906 compound necrosis,factor
R1984 T3906 T3903 pobj factor,of
R1985 T3907 T3908 punct (,TNF
R1988 T3908 T3906 appos TNF,factor
R1990 T3909 T3900 punct ),obtained
R1993 T3910 T3899 punct -,benefits
R1997 T3911 T3911 ROOT α,α
R2000 T3912 T3911 punct ),α
R2004 T3913 T3911 cc and,α
R2008 T3914 T3919 nsubj interleukin,suggest
R2012 T3915 T3916 punct (,IL
R2015 T3916 T3914 appos IL,interleukin
R2019 T3917 T3918 punct ),-1
R2023 T3918 T3919 nsubj -1,suggest
R2026 T3919 T3911 conj suggest,α
R2033 T3920 T3928 mark that,been
R2037 T3921 T3922 det the,blockade
R2041 T3922 T3928 nsubj blockade,been
R2045 T3923 T3922 prep of,blockade
R2048 T3924 T3926 amod key,cytokines
R2052 T3925 T3926 amod inflammatory,cytokines
R2056 T3926 T3923 pobj cytokines,of
R2060 T3927 T3928 aux has,been
R2064 T3928 T3919 ccomp been,suggest
R2068 T3929 T3931 det the,issue
R2071 T3930 T3931 amod important,issue
R2075 T3931 T3928 attr issue,been
R2079 T3932 T3931 prep in,issue
R2081 T3933 T3934 det the,development
R2084 T3934 T3932 pobj development,in
R2087 T3935 T3934 prep of,development
R2091 T3936 T3938 amod new,applications
R2095 T3937 T3938 amod therapeutic,applications
R2097 T3938 T3935 pobj applications,of
R2100 T3939 T3941 amod [,]
R2104 T3940 T3941 nummod 2,]
R2107 T3941 T3931 conj ],issue
R2111 T3942 T3919 punct .,suggest